You searched for "pathology"

1345 results found

The Eye in History

Amongst the numerous texts that are available, one occasionally encounters a history of ophthalmology. There is such rapid development of technology in recent years and one can get drawn into the minutiae of a particular subject, losing track of the...

Rayner announces acquisition of Sophi

Rayner, a global leader in products for cataract surgery headquartered in Worthing, UK, announced today (17 January 2024) that it has entered into a definitive agreement to acquire Swiss-based This AG, the inventor, developer and manufacturer of Sophi phaco emulsification machines.

Oertli Instrumente AG wins the Swiss Medtech Award

Oertli Instrumente AG has been honored with the prestigious Swiss Medtech Award, worth CHF 75,000 at the Swiss Medtech Day.

Glaukos Launches iStent infinite® in the UK Following MDR Approval

Glaukos has announced the launch of its latest glaucoma treatment, iStent infinite®, in the UK market after securing approval under the European Medical Device Regulation (MDR). This new approval process is rigorous and provides ophthalmologists with reassurance regarding the efficacy...

In conversation with Charles Leclercq (ARxVision)

Julian Jackson (Founder and Director, VisionBridge) spoke to Charles Leclercq (CEO, ARx) about the ARxVision, a wearable device that captures the world around us through audio and artificial intelligence to empower blind and low-vision individuals. You can read the Eye...

Visual disturbance heralding stroke: are we seeing the signs in time?

Isolated visual symptoms may be an early presenting feature of stroke, and timely recognition of such atypical cases is important because treatment for stroke has a limited time-window of efficacy. Stroke occurs in approximately 150,000 people per year in the...

Broadening of treatment options for potentially blinding retinal conditions

Rod McNeil provides an update on a promising bispecific antibody recently approved for treatment of neovascular age-related macular degeneration (nAMD) and diabetic macular oedema (DMO) and considers emerging developments in biosimilars to established anti-vascular endothelial growth factor (anti-VEGF) therapies, including...

The management of antiplatelets and anticoagulation in elective ophthalmic surgery

Clinical scenario: A 57-year-old gentleman who is scheduled to have Mohs micrographic surgery and reconstruction for a medial canthal basel cell carcinoma (BCC) has been started on aspirin and clopidogrel following a coronary stent three weeks ago. Does the antiplatelet...

New funding will support development of wearable diagnostics for neuromuscular diseases

A researcher from the University of Glasgow has received an EPSRC Open Fellowship to develop new wearable technology capable of measuring the progress of neuromuscular diseases.

Orbis and Heidelberg Engineering team up on free e-learning opportunities

Sight-saving charity Orbis and high-tech imaging and data solutions company Heidelberg Engineering are leveraging technology to provide free clinical education for eye care professionals around the world.

Pioneering accessible technology conference returns to Glasgow in 2025

RNIB Scotland’s Inclusive Design for Sustainability (IDS) Conference is set to return to Glasgow Science Centre on 17 and 18 March 2025, bringing together global tech giants and accessibility advocates to explore the future of inclusive design. The event, which...

30 Years of Vision: Crafting the Next Decade

Centre for Sight 30 Years of Vision: Crafting the Next Decade